These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30273675)

  • 21. Enrichment of high-functioning human iPS cell-derived hepatocyte-like cells for pharmaceutical research.
    Takayama K; Hagihara Y; Toba Y; Sekiguchi K; Sakurai F; Mizuguchi H
    Biomaterials; 2018 Apr; 161():24-32. PubMed ID: 29421559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of Canine Induced Extraembryonic Endoderm-Like Cell Line That Forms Both Extraembryonic and Embryonic Endoderm Derivatives.
    Nishimura T; Unezaki N; Kanegi R; Wijesekera DPH; Hatoya S; Sugiura K; Kawate N; Tamada H; Imai H; Inaba T
    Stem Cells Dev; 2017 Aug; 26(15):1111-1120. PubMed ID: 28474540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.
    Chou BK; Gu H; Gao Y; Dowey SN; Wang Y; Shi J; Li Y; Ye Z; Cheng T; Cheng L
    Stem Cells Transl Med; 2015 Apr; 4(4):320-32. PubMed ID: 25742692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells.
    Sekine K; Takebe T; Suzuki Y; Kamiya A; Nakauchi H; Taniguchi H
    Transplant Proc; 2012 May; 44(4):1127-9. PubMed ID: 22564643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity.
    Kondo Y; Iwao T; Nakamura K; Sasaki T; Takahashi S; Kamada N; Matsubara T; Gonzalez FJ; Akutsu H; Miyagawa Y; Okita H; Kiyokawa N; Toyoda M; Umezawa A; Nagata K; Matsunaga T; Ohmori S
    Drug Metab Pharmacokinet; 2014; 29(3):237-43. PubMed ID: 24334537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic nanofibrillar matrix promotes in vitro hepatic differentiation of embryonic stem cells and induced pluripotent stem cells.
    Yamazoe T; Shiraki N; Toyoda M; Kiyokawa N; Okita H; Miyagawa Y; Akutsu H; Umezawa A; Sasaki Y; Kume K; Kume S
    J Cell Sci; 2013 Dec; 126(Pt 23):5391-9. PubMed ID: 24101719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective culture method for hepatocyte-like cells differentiated from human induced pluripotent stem cells.
    Kondo Y; Yoshihashi S; Mimori K; Ogihara R; Kanehama Y; Maki Y; Enosawa S; Kurose K; Iwao T; Nakamura K; Matsunaga T
    Drug Metab Pharmacokinet; 2014; 29(5):407-13. PubMed ID: 24785642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different murine-derived feeder cells alter the definitive endoderm differentiation of human induced pluripotent stem cells.
    Shoji M; Minato H; Ogaki S; Seki M; Suzuki Y; Kume S; Kuzuhara T
    PLoS One; 2018; 13(7):e0201239. PubMed ID: 30048506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of qualified clinical-grade functional hepatocytes from human embryonic stem cells in chemically defined conditions.
    Li Z; Wu J; Wang L; Han W; Yu J; Liu X; Wang Y; Zhang Y; Feng G; Li W; Stacey GN; Gu Q; Hu B; Wang L; Zhou Q; Hao J
    Cell Death Dis; 2019 Oct; 10(10):763. PubMed ID: 31601782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF signal is not required for hepatoblast differentiation of human iPS cells.
    Toba Y; Kiso A; Nakamae S; Sakurai F; Takayama K; Mizuguchi H
    Sci Rep; 2019 Mar; 9(1):3713. PubMed ID: 30842525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic differentiation of human pluripotent stem cells on human liver progenitor HepaRG-derived acellular matrix.
    Kanninen LK; Porola P; Niklander J; Malinen MM; Corlu A; Guguen-Guillouzo C; Urtti A; Yliperttula ML; Lou YR
    Exp Cell Res; 2016 Feb; 341(2):207-17. PubMed ID: 26854693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes.
    Qiu S; Li Y; Imakura Y; Mima S; Hashita T; Iwao T; Matsunaga T
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient differentiation of functional hepatocytes from human embryonic stem cells.
    Agarwal S; Holton KL; Lanza R
    Stem Cells; 2008 May; 26(5):1117-27. PubMed ID: 18292207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c/EBPα, and PROX1 transduction.
    Nakamori D; Takayama K; Nagamoto Y; Mitani S; Sakurai F; Tachibana M; Mizuguchi H
    Biochem Biophys Res Commun; 2016 Jan; 469(3):424-9. PubMed ID: 26679606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic Differentiation from Murine and Human iPS Cells Using Nanofiber Scaffolds.
    Yamazoe T; Shiraki N; Kume S
    Methods Mol Biol; 2016; 1357():475-83. PubMed ID: 25410288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2‑Deoxy‑D‑glucose initiates hepatocyte differentiation in human induced pluripotent stem cells.
    Tomizawa M; Shinozaki F; Motoyoshi Y; Sugiyama T; Yamamoto S; Ishige N
    Mol Med Rep; 2017 May; 15(5):3083-3087. PubMed ID: 28358426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Billion-scale production of hepatocyte-like cells from human induced pluripotent stem cells.
    Yamashita T; Takayama K; Sakurai F; Mizuguchi H
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1269-1275. PubMed ID: 29409945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails.
    Du C; Feng Y; Qiu D; Xu Y; Pang M; Cai N; Xiang AP; Zhang Q
    Stem Cell Res Ther; 2018 Mar; 9(1):58. PubMed ID: 29523187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient differentiation of embryonic stem cells into hepatic cells in vitro using a feeder-free basement membrane substratum.
    Shiraki N; Yamazoe T; Qin Z; Ohgomori K; Mochitate K; Kume K; Kume S
    PLoS One; 2011; 6(8):e24228. PubMed ID: 21887386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
    Deguchi S; Yamashita T; Igai K; Harada K; Toba Y; Hirata K; Takayama K; Mizuguchi H
    Drug Metab Dispos; 2019 Jun; 47(6):632-638. PubMed ID: 30962288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.